The association between injectable non-steroidal anti-inflammatory drugs and acute kidney injury in dogs and cats
Open Access
- 23 September 2025
- journal article
- review article
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 52 (6) , 730-736
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Robenacoxib versus meloxicam following ovariohysterectomy in cats: A randomised, prospective clinical trial involving owner‐based assessment of painVeterinary Record, 2023
- Non-steroidal Anti-inflammatory Drugs: Clinical Implications, Renal Impairment Risks, and AKIAdvances in Therapy, 2023
- The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humansTherapies, 2022
- Kidney damage from nonsteroidal anti‐inflammatory drugs—Myth or truth? Review of selected literaturePharmacology Research & Perspectives, 2021
- Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?The Lancet, 2021
- Effect of non-steroidal anti-inflammatory drugs on glomerular filtration rate and urinary N-acetyl-β-D-glucosaminidase activity in cats after dental surgeryVeterinary Anaesthesia and Analgesia, 2020
- An analysis of the relative frequencies of reported adverse events associated with NSAID administration in dogs and cats in the United KingdomThe Veterinary Journal, 2015
- Drug withdrawals and the utilization of therapeutic substitutes: The case of VioxxJournal of Economic Behavior & Organization, 2013
- Retrospective Case—Control Study of the Effects of Long-Term Dosing with Meloxicam on Renal Function in Aged Cats with Degenerative Joint DiseaseJournal of Feline Medicine and Surgery, 2011
- Reye's Syndrome in the United States from 1981 through 1997New England Journal of Medicine, 1999